GlassScriptPhysician profile
James Gregory Malcolm
NPI 1225562739
$9,091.45
in general payments reported to CMS, 2019-2025
17 companies · $3,439 in 2025
The $3,439 reported for 2025 was more than what 76% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $5,652 · 2025: $3,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,029 · Food and Beverage: $2,178 · Royalty Or License: $1,884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,029.10 |
| Food and Beverage | $2,178.35 |
| Royalty Or License | $1,884.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $1,894.50 | 2024-2025 | Other - Miscellaneous, Invictus Mis, Identiti |
| Spineart Sa | $1,884.00 | 2025 | Cure Acp - Anterior Cervical Plate |
| Medtronic, INC. | $1,433.27 | 2024-2025 | Catalyft Pl Expandable Interbody System, Divergence-L Anterior/Oblique Lumbar Fusion System, Inceptiv |
| Aesculap Implant Systems, LLC | $936.89 | 2024 | Activl |
| Globus Medical, INC. | $775.22 | 2024 | Elsa, Excelsiusgps Robotic Navigation System |
| Spineart USA INC | $617.59 | 2025 | |
| Ossdsign USA Incorporated | $440.69 | 2024-2025 | Ossdsign Catalyst |
| Stryker Corporation | $313.01 | 2024-2025 | Yukon Oct Spinal System, Everest Spinal System |
| Intrinsic Therapeutics | $209.01 | 2025 | Barricaid Acd (Annular Closure Device) |
| Depuy Synthes Sales INC. | $144.24 | 2024-2025 | Skyline, Fibergraft Bg Morsels, Expedium Verse |
| Vertex Pharmaceuticals Incorporated | $121.86 | 2025 | |
| Cerapedics INC. | $118.16 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Microtransponder, INC. | $110.45 | 2025 | |
| Si-Bone, INC. | $29.74 | 2025 | |
| Janssen Biotech, INC. | $23.15 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $21.44 | 2024 | |
| Abbott Laboratories | $18.23 | 2025 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Malcolm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.